FDA officials said that the draft guidance is meant to address recommendations from two reports on the agency's response to COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback